Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases

被引：0
|
作者：
Saburi, Masuho [1 ]
Nishikawa, Takumi [1 ]
Miyazaki, Yasuhiko [1 ]
Kohno, Kazuhiro [2 ]
Sakata, Masanori [3 ]
Okuhiro, Kazuki [3 ]
Nakayama, Toshiyuki [2 ]
Ohtsuka, Eiichi [1 ]
Ogata, Masao [2 ,3 ]
机构：
[1] Oita Prefectural Hosp, Dept Hematol, 8-1 Bunyo 2 Chome, Oita City, Oita 8708511, Japan
[2] Oita Kouseiren Tsurumi Hosp, Dept Hematol, Oita, Japan
[3] Oita Univ Hosp, Dept Hematol, Oita, Japan
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY | 2024年 / 64卷 / 02期
关键词：
chronic lymphocytic leukemia; small lymphocytic lymphoma; venetoclax; rituximab; Japanese; OPEN-LABEL; PHASE-3; CHEMOIMMUNOTHERAPY; CYCLOPHOSPHAMIDE; FLUDARABINE;
D O I：
10.3960/jslrt.24014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：152 / 155
页数：4
相关论文
共 50 条
  • [1] Real-world duration of venetoclax treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma
    Teschemaker, Anna
    Hakre, Shweta
    Tse, Jenny
    Shaikh, Nazneen Fatima
    Gu, Yifan
    Near, Aimee
    LEUKEMIA & LYMPHOMA, 2023, 64 : S62 - S63
  • [2] Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Lei, Matthew M.
    Sorial, Mark N.
    Lou, Uvette
    Yu, Michelle
    Medrano, Andrea
    Ford, Josie
    Nemec, Ronald A.
    Abramson, Jeremy S.
    Soumerai, Jacob D.
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 653 - 659
  • [3] A Real-World Study of Zanubrutinib Treatment in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Zhu, Huayuan
    Xia, Yi
    Miao, Yi
    Qin, Shuchao
    Wu, Wei
    Qiu, Tonglu
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2023, 142
  • [4] Effectivness and Safety of Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective, Real-World Study in China
    Ding, Kaiyang
    Cheng, Yue-Xin
    Wang, Xiaoyong
    Huang, Chen
    Liang, Yang
    Li, Wei
    Ye, Jingjing
    Ji, Chunyan
    BLOOD, 2023, 142
  • [5] Real-world time to discontinuation of first-line venetoclax plus binutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023,
  • [6] Real-world time to discontinuation of first-line venetoclax plus obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, : 1227 - 1235
  • [7] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Xiao, Yue
    Huang, Ruijian
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [8] The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
    Schieber, Michael
    Ma, Shuo
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2019, 9 : 9 - 17
  • [9] Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience
    Laurenti, Luca
    Scarfo, Lydia
    Frustaci, Anna Maria
    Sanna, Alessandro
    Iannella, Emilia
    Caira, Morena
    Finsinger, Paola
    Schifano, Silvia
    Neri, Benedetta
    Molica, Stefano
    Mauro, Francesca Romana
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 621 - 630
  • [10] Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis
    Kittai, Adam S.
    Hang, Ying
    Bhat, Seema A.
    Clark, Abi
    Grever, Michael
    Rhodes, Joanna M.
    Roberts, Melyssa
    Rogers, Kerry A.
    Teschemaker, Anna
    Munoz-Sagastibelza, Maria
    Woyach, Jennifer A.
    Barrientos, Jacqueline C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (04) : 780 - 784
12345